$309.88
1.69%
Nasdaq, Oct 10, 10:05 pm CET
ISIN
US98980G1022
Symbol
ZS
Index
Industry

Zscaler, Inc. Target price 2025 - Analyst rating & recommendation

Zscaler, Inc. Classifications & Recommendation:

Buy
77%
Hold
23%

Zscaler, Inc. Price Target

Target Price $336.60
Price $309.88
Potential 8.62%
Number of Estimates 48
48 Analysts have issued a price target Zscaler, Inc. 2026 . The average Zscaler, Inc. target price is $336.60. This is 8.62% higher than the current stock price. The highest price target is $404.25 30.45% , the lowest is $217.15 29.92% .
A rating was issued by 56 analysts: 43 Analysts recommend Zscaler, Inc. to buy, 13 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Zscaler, Inc. stock has an average upside potential 2026 of 8.62% . Most analysts recommend the Zscaler, Inc. stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2032


Jul '25 2026
Estimates
Revenue Billion $ 2.67 3.38
23.31% 26.33%
EBITDA Margin -4.55% 26.24%
17.58% 676.40%
Net Margin -1.55% 17.77%
41.71% 1,245.16%

52 Analysts have issued a sales forecast Zscaler, Inc. 2026 . The average Zscaler, Inc. sales estimate is $3.4b . This is 26.33% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $3.5b 31.53% , the lowest is $3.2b 19.75% .

This results in the following potential growth metrics:

Revenue Estimates

2025 $2.7b 23.31%
2026 $3.4b 26.33%
2027 $4.0b 19.66%
2028 $4.8b 18.93%
2029 $5.8b 20.37%
2030 $6.9b 18.96%
2031 $8.1b 18.41%
2032 $9.6b 17.87%

22 Analysts have issued an Zscaler, Inc. EBITDA forecast 2026. The average Zscaler, Inc. EBITDA estimate is $886m . This is 836.02% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $938m 879.35% , the lowest is $807m 770.57% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-122m 1.64%
2026 $886m 828.10%
2027 $1.1b 23.25%
2028 $1.3b 23.17%

EBITDA Margin

2025 -4.55% 17.58%
2026 26.24% 676.40%
2027 27.02% 2.97%
2028 27.99% 3.59%

51 Zscaler, Inc. Analysts have issued a net profit forecast 2026. The average Zscaler, Inc. net profit estimate is $600m . This is 1,546.50% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $710m 1,811.04% , the lowest is $565m 1,460.97% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-41.5m 28.12%
2026 $600m 1,546.50%
2027 $722m 20.35%
2028 $885m 22.48%
2029 $1.1b 28.67%
2030 $1.4b 24.14%
2031 $1.9b 33.18%
2032 $2.4b 29.55%

Net Margin

2025 -1.55% 41.71%
2026 17.77% 1,245.16%
2027 17.87% 0.56%
2028 18.40% 2.97%
2029 19.67% 6.90%
2030 20.53% 4.37%
2031 23.09% 12.47%
2032 25.38% 9.92%

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032


Jul '25 2026
Estimates
Earnings Per Share $ -0.27 3.79
30.77% 1,503.70%
P/E 81.76

51 Analysts have issued a Zscaler, Inc. forecast for earnings per share. The average Zscaler, Inc. EPS is $3.79 . This is 1,503.70% higher than earnings per share in the financial year 2025. The highest EPS forecast is $4.48 1,759.26% , the lowest is $3.57 1,422.22% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.27 30.77%
2026 $3.79 1,503.70%
2027 $4.56 20.32%
2028 $5.59 22.59%
2029 $7.19 28.62%
2030 $8.92 24.06%
2031 $11.89 33.30%
2032 $15.40 29.52%

P/E ratio

Current -1,147.70 163.95%
2026 81.76 107.12%
2027 67.93 16.92%
2028 55.46 18.36%
2029 43.10 22.29%
2030 34.72 19.44%
2031 26.07 24.91%
2032 20.12 22.82%

Current Zscaler, Inc. Upgrades & Downgrades

Analyst Rating Action Date
RBC Capital
Outperform
Outperform
Unchanged Oct 02 2025
Canaccord Genuity
Buy
Buy
Unchanged Sep 04 2025
BMO Capital
Outperform
Outperform
Unchanged Sep 03 2025
Guggenheim
Neutral
Neutral
Unchanged Sep 03 2025
Cantor Fitzgerald
Overweight
Overweight
Unchanged Sep 03 2025
Barclays
Overweight
Overweight
Unchanged Sep 03 2025
Baird
Outperform
Outperform
Unchanged Sep 03 2025
Analyst Rating Date
Unchanged
RBC Capital:
Outperform
Outperform
Oct 02 2025
Unchanged
Canaccord Genuity:
Buy
Buy
Sep 04 2025
Unchanged
BMO Capital:
Outperform
Outperform
Sep 03 2025
Unchanged
Guggenheim:
Neutral
Neutral
Sep 03 2025
Unchanged
Cantor Fitzgerald:
Overweight
Overweight
Sep 03 2025
Unchanged
Barclays:
Overweight
Overweight
Sep 03 2025
Unchanged
Baird:
Outperform
Outperform
Sep 03 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today